Abstract
We have compared the EBV‐receptor concentration of two originally EBV‐negattve human B‐cell lymphoma lines, after in vitro conversion with the transforming B95‐8 or the cytopathic P3HR‐1 EB‐viral substrain, respectively, into permanent EBV‐carrying sublines. Receptors were measured by the quantitative EBV‐absorption bioassay of Sairenji and Hinuma (1973). EBV receptor concentration of all P3HR‐1 virus‐converted sublines was significantly reduced, in comparison with the B95‐8 virus‐converted sublines. This suggests that cells with a low receptor concentration are more likely to survive the initial infection with the P3HR‐1 viral harvest. The results further confirm the biological differences between the two EBV substrains.
| Original language | English |
|---|---|
| Pages (from-to) | 197-200 |
| Number of pages | 4 |
| Journal | International Journal of Cancer |
| Volume | 23 |
| Issue number | 2 |
| DOIs | |
| State | Published - 15 Feb 1979 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Differences in EBV receptor concentration between in vitro EBV‐converted lymphoma sublines reflect biological differences between the converting viral substrains'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver